Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Sonidegib often causes hair loss, and LC-OCT helps identify early signs.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Caizhixuan hair tonic helps treat hair loss by promoting hair growth and improving hair follicles.

Repurposing existing drugs can improve cancer treatment but faces challenges.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Ritlecitinib is an effective new treatment for Alopecia Areata.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Ozenoxacin reduces sebum production, helping manage acne.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Cetuximab can cause eyelash growth, which is rare but manageable.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

Sonidegib and vismodegib have different side effects and reporting patterns.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.